Skip to main content

The first-in-class disease-modifying drug for chronic airway disorders

Project description

A novel disease-modifying drug for chronic obstructive pulmonary disease

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Coordinator

EpiEndo Pharmaceuticals ehf
Address
Eidistorg 13-15, 3Rd Floor, Innovation House
170 Seltjarnarnes
Iceland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 500 000